NDC:59338-775-01活性物质:FERUMOXYTOL剂量:510 mg/ 17 mL服用方式:静脉注射NDA:NDA022180 首次上市时间:07/13/2009分销商:AMAG Pharmaceuticals, Inc.生产商一:Baxter Pharmaceutical Solutions生产商二:Patheon Manufacturing Services LLC说明书:PDF
药品编号 06349838 持证商 MCM KLOSTERFRAU Vertr. GmbH 包装规格 100 St Packungsnorm N3 产品名 Soledum Kapseln 100mg 剂型 Kapseln magensaftresistent Monopräparat ja 活性物质 Cineol 需要医生开处方 nein Apothekenpflichtig ja 信息来源:https://www.besamex.de/produkt/soledum-100-mg-magensaftresistente-kapseln-100-st-06349838.html
产品名称：ABILIFY ASIMTUFII上市时间：04/27/2023NDA/ANDA/BLA:217006持证商：OTSUKANDC:59148-102-80,59148-114-80说明书：https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217006s000lbl.pdf批准信：https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/217006Orig1s000ltr.pdf
产品名称：CHLORZOXAZONE上市时间：04/27/2023NDA/ANDA/BLA:214365持证商：ACME LABSNDC:说明书：批准信：
产品名称：THALIDOMIDE上市时间：04/27/2023NDA/ANDA/BLA:213267持证商：NATCONDC:说明书：批准信：https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/213267Orig1s000ltr.pdf
产品名称：THALIDOMIDE上市时间：04/27/2023NDA/ANDA/BLA:213267持证商：NATCONDC:说明书：批准信：https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/213267Orig1s000ltr.pdf
产品名称：ESOMEPRAZOLE MAGNESIUM上市时间：04/27/2023NDA/ANDA/BLA:211977持证商：HETERO LABS LTD IIINDC:71335-2040-1,71335-2040-2,71335-2040-3,71335-2040-4,71335-2040-5,71335-2040-6,71335-2040-7,68071-2649-9,80425-0331-1,80425-0331-2,80425-0331-3,31722-664-10,31722-664-30,31722-664-90,31722-665-10,31722-665-30,3172...
产品名称：ESOMEPRAZOLE MAGNESIUM上市时间：04/27/2023NDA/ANDA/BLA:211977持证商：HETERO LABS LTD IIINDC:71335-2040-1,71335-2040-2,71335-2040-3,71335-2040-4,71335-2040-5,71335-2040-6,71335-2040-7,68071-2649-9,80425-0331-1,80425-0331-2,80425-0331-3,31722-664-10,31722-664-30,31722-664-90,31722-665-10,31722-665-30,3172...
产品名称：OLOPATADINE HYDROCHLORIDE上市时间：04/27/2023NDA/ANDA/BLA:210901持证商：AMNEALNDC:65162-890-23说明书：批准信：https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=806e8d0f-ff42-4d6e-b840-49e3bf867cb5&type=pdf
产品名称：DRONEDARONE上市时间：04/27/2023NDA/ANDA/BLA:210678持证商：AUROBINDO PHARMA LTDNDC:说明书：批准信：https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/210678Orig1s000TA_ltr.pdf
产品名称：DROSPIRENONE AND ETHINYL ESTRADIOL上市时间：04/27/2023NDA/ANDA/BLA:90081持证商：DR REDDYS LABS SANDC:说明书：批准信：https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/090081s000ltr.pdf
产品名称：DROSPIRENONE AND ETHINYL ESTRADIOL上市时间：04/27/2023NDA/ANDA/BLA:90081持证商：DR REDDYS LABS SANDC:说明书：批准信：https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/090081s000ltr.pdf
